CINVANTI

Product NDC
47426-201
11-digit product format
474260201
Labeler code
47426
Product ID
47426-201_94c147fd-c8bd-428c-911b-f1aba4ab8729
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
aprepitant
Dosage form
INJECTION, EMULSION
Route
INTRAVENOUS
Labeler
Heron Therapeutics, Inc.
Application
NDA209296
Marketing category
NDA
Marketing start
2018-01-03
Substance
APREPITANT
Active strength
130 mg/18mL
Pharmacologic classes
Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
CINVANTI
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
APREPITANT130 mg/18mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii1NF15YR6UY
Rxcui1995150, 1995155

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
2abc3e32-ae1f-4dec-be1c-0c39ac95b38eProduct name720240514
5d352eda-d4de-4572-9a3f-32d6fd204f9aProduct name120230911
3a5d67cc-4a03-45a3-8d74-5aeb67631be4Product name120230831
85fc66a9-58b2-e194-7cdb-89ff44dcf3e6Product name420210518
baf7f49c-75b6-496b-a00e-8e766a8e4f03Product name120210127
9f9a82fd-fcee-442f-9233-7f2d2f9f4568Product name120180108
ebc62596-fc97-4d03-9483-7ba095d25db7Product name120151210
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
47426-201-01CINVANTI1 in 1 CARTONINJECTION, EMULSION115
47426-201-01CINVANTI18 mL in 1 VIAL, GLASSINJECTION, EMULSION1815

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
47426-201CINVANTI (APREPITANT) INJECTION, EMULSION [HERON THERAPEUTICS, INC.]12Current NDC, Legacy NDC, 2 package rows20240319_4c218d3a-a508-4abc-9ed8-a6e8e191d1b4.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1995150aprepitant 130 MG in 18 ML InjectionPSN4c218d3a-a508-4abc-9ed8-a6e8e191d1b415
1995155CINVANTI 130 MG in 18 ML InjectionPSN4c218d3a-a508-4abc-9ed8-a6e8e191d1b415
199515518 ML aprepitant 7.2 MG/ML Injection [Cinvanti]SBD4c218d3a-a508-4abc-9ed8-a6e8e191d1b415
199515018 ML aprepitant 7.2 MG/ML InjectionSCD4c218d3a-a508-4abc-9ed8-a6e8e191d1b415
1995150aprepitant 130 MG per 18 ML InjectionSY4c218d3a-a508-4abc-9ed8-a6e8e191d1b415
1995155Cinvanti 130 MG per 18 ML InjectionSY4c218d3a-a508-4abc-9ed8-a6e8e191d1b415
1995155Cinvanti 7.2 MG/ML per 18 ML InjectionSY4c218d3a-a508-4abc-9ed8-a6e8e191d1b415

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
47426-201-01474260201011 VIAL, GLASS in 1 CARTON (47426-201-01) / 18 mL in 1 VIAL, GLASS2018-01-030000-00-00NoNoCurrent